Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-06 Sale | 2026-07-08 8:21 pm | PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner | 44,058 | $8.263 | $364,051 | 7,261,671 (Direct) | View |
| 2026-07-06 Sale | 2026-07-08 8:19 pm | PUMA BIOTECHNOLOGY INC. | PBYI | HUNT DOUGLAS M See Remarks | 8,460 | $8.263 | $69,905 | 196,841 (Direct) | View |
| 2026-07-06 Sale | 2026-07-08 8:18 pm | PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer | 9,386 | $8.263 | $77,557 | 230,637 (Direct) | View |
| 2026-06-12 Sale | 2026-06-15 8:16 pm | PUMA BIOTECHNOLOGY INC. | PBYI | WILSON TROY EDWARD Director | 10,800 | $7.1989 | $77,748 | 60,300 (Indirect Direct) | View |
| 2026-06-12 Sale | 2026-06-15 8:14 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Stuglik Brian M Director | 8,100 | $7.1989 | $58,311 | 113,858 (Direct) | View |
| 2026-06-12 Sale | 2026-06-15 8:13 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Senderowicz Adrian Director | 27,000 | $7.1967 | $194,311 | 27,000 (Direct) | View |
| 2026-06-12 Sale | 2026-06-15 8:10 pm | PUMA BIOTECHNOLOGY INC. | PBYI | MOYES JAY M Director | 22,000 | $7.218 | $158,796 | 58,322 (Direct) | View |
| 2026-06-12 Sale | 2026-06-15 8:09 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director | 11,610 | $7.1989 | $83,579 | 90,780 (Direct) | View |
| 2026-01-06 Sale | 2026-01-08 8:27 pm | PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner | 34,950 | $5.862 | $204,878 | 7,145,951 (Direct) | View |
| 2026-01-06 Sale | 2026-01-08 8:15 pm | PUMA BIOTECHNOLOGY INC. | PBYI | HUNT DOUGLAS M See Remarks | 8,987 | $5.8635 | $52,696 | 155,907 (Direct) | View |
| 2026-01-06 Sale | 2026-01-08 8:14 pm | PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer | 10,945 | $5.8645 | $64,187 | 193,284 (Direct) | View |
| 2025-11-11 Sale | 2025-11-13 4:41 pm | PUMA BIOTECHNOLOGY INC. | PBYI | MILLER MICHAEL PATRICK Director | 20,000 | $4.8614 | $97,228 | 54,000 (Direct) | View |
| 2025-07-18 Sale | 2025-07-22 7:51 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Cesano Alessandra Director | 27,000 | $3.367 | $90,909 | 41,850 (Direct) | View |
| 2025-07-08 Sale | 2025-07-10 8:56 pm | PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer | 9,522 | $3.5338 | $33,649 | 204,229 (Direct) | View |
| 2025-07-08 Sale | 2025-07-10 8:52 pm | PUMA BIOTECHNOLOGY INC. | PBYI | HUNT DOUGLAS M See Remarks | 7,817 | $3.5339 | $27,624 | 164,894 (Direct) | View |
| 2025-07-08 Sale | 2025-07-10 8:49 pm | PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner | 47,172 | $3.5339 | $166,702 | 7,180,901 (Direct) | View |
| 2025-06-13 Sale | 2025-06-17 7:55 pm | PUMA BIOTECHNOLOGY INC. | PBYI | WILSON TROY EDWARD Director | 10,800 | $3.4 | $36,720 | 44,100 (Indirect Direct) | View |
| 2025-06-13 Sale | 2025-06-17 7:52 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Stuglik Brian M Director | 8,100 | $3.39 | $27,459 | 94,958 (Direct) | View |
| 2025-06-13 Sale | 2025-06-17 7:49 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Senderowicz Adrian Director | 27,000 | $3.4 | $91,800 | 27,000 (Direct) | View |
| 2025-06-13 Sale | 2025-06-17 7:46 pm | PUMA BIOTECHNOLOGY INC. | PBYI | MOYES JAY M Director | 22,000 | $3.4 | $74,800 | 53,322 (Direct) | View |
| 2025-06-13 Sale | 2025-06-17 7:43 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director | 11,610 | $3.4 | $39,474 | 75,390 (Direct) | View |
| 2025-06-13 Sale | 2025-06-17 7:41 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Cesano Alessandra Director | 12,150 | $3.4 | $41,310 | 68,850 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 7:33 pm | PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer | 10,227 | $3.1517 | $32,232 | 152,295 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 7:31 pm | PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer | 9,437 | $3.1517 | $29,743 | 108,951 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-06-11 Option Award | 2026-06-15 8:16 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | WILSON TROY EDWARD Director | 27,000 | $0 | 60,300 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 8:14 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Stuglik Brian M Director | 27,000 | $0 | 113,858 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 8:13 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Senderowicz Adrian Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 8:12 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | MILLER MICHAEL PATRICK Director | 27,000 | $0 | 81,000 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 8:10 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | MOYES JAY M Director | 27,000 | $0 | 58,322 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 8:09 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director | 27,000 | $0 | 90,780 (Direct) | View |
| 2026-06-11 Option Award | 2026-06-15 8:07 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Cesano Alessandra Director | 27,000 | $0 | 68,850 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 8:29 pm | N/A 2036-02-17 | PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner | 387,252 | $0 | 7,533,203 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 8:28 pm | N/A 2036-02-17 | PUMA BIOTECHNOLOGY INC. | PBYI | HUNT DOUGLAS M See Remarks | 119,715 | $0 | 275,622 (Direct) | View |
| 2026-02-18 Option Award | 2026-02-20 8:28 pm | N/A 2036-02-17 | PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer | 113,280 | $0 | 306,564 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 8:19 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | MILLER MICHAEL PATRICK Director | 27,000 | $0 | 74,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 8:18 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Senderowicz Adrian Director | 27,000 | $0 | 54,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 8:16 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | MOYES JAY M Director | 27,000 | $0 | 75,322 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 8:14 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Dorval Allison Director | 27,000 | $0 | 87,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 8:12 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Stuglik Brian M Director | 27,000 | $0 | 103,058 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 8:11 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | WILSON TROY EDWARD Director | 27,000 | $0 | 54,900 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 8:10 pm | N/A N/A | PUMA BIOTECHNOLOGY INC. | PBYI | Cesano Alessandra Director | 27,000 | $0 | 81,000 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-11 6:58 pm | N/A 2035-02-06 | PUMA BIOTECHNOLOGY INC. | PBYI | NOUGUES MAXIMO F Chief Financial Officer | 146,523 | $0 | 298,818 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-11 6:55 pm | N/A 2035-02-06 | PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer | 114,062 | $0 | 223,013 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-11 6:53 pm | N/A 2035-02-06 | PUMA BIOTECHNOLOGY INC. | PBYI | HUNT DOUGLAS M See Remarks | 114,721 | $0 | 239,315 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-11 6:51 pm | N/A 2035-02-06 | PUMA BIOTECHNOLOGY INC. | PBYI | AUERBACH ALAN H President and CEO 10% Owner | 473,021 | $0 | 7,502,695 (Direct) | View |